Maonan Wang

2.1k total citations · 1 hit paper
35 papers, 1.5k citations indexed

About

Maonan Wang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Maonan Wang has authored 35 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Maonan Wang's work include Nanocluster Synthesis and Applications (5 papers), RNA modifications and cancer (5 papers) and Ferroptosis and cancer prognosis (4 papers). Maonan Wang is often cited by papers focused on Nanocluster Synthesis and Applications (5 papers), RNA modifications and cancer (5 papers) and Ferroptosis and cancer prognosis (4 papers). Maonan Wang collaborates with scholars based in China, United States and Singapore. Maonan Wang's co-authors include Wei Xiong, Can Guo, Zhaoyang Zeng, Guiyuan Li, Zhaojian Gong, Yu Lian, Jianda Zhou, Xiayu Li, Ke Cao and Yingfeng Wu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Maonan Wang

31 papers receiving 1.5k citations

Hit Papers

Role of tumor microenvironment in tumorigenesis 2017 2026 2020 2023 2017 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maonan Wang China 14 663 483 394 323 314 35 1.5k
Serena Marchiò Italy 25 990 1.5× 494 1.0× 273 0.7× 285 0.9× 245 0.8× 45 1.9k
Shuyang Sun China 25 884 1.3× 502 1.0× 354 0.9× 181 0.6× 319 1.0× 46 1.6k
Madeleine M. Handsley United Kingdom 8 772 1.2× 591 1.2× 525 1.3× 179 0.6× 248 0.8× 9 1.8k
Yuliang Ran China 23 689 1.0× 345 0.7× 348 0.9× 153 0.5× 225 0.7× 55 1.5k
Nimali P. Withana United States 12 479 0.7× 517 1.1× 316 0.8× 261 0.8× 224 0.7× 17 1.2k
Stefanie Mullins United States 13 491 0.7× 766 1.6× 312 0.8× 301 0.9× 221 0.7× 18 1.3k
Yu Yao China 24 743 1.1× 378 0.8× 326 0.8× 207 0.6× 430 1.4× 62 1.6k
Simona Serratì Italy 25 854 1.3× 370 0.8× 500 1.3× 347 1.1× 133 0.4× 57 1.6k
Varvara Petrova Italy 9 529 0.8× 412 0.9× 426 1.1× 254 0.8× 220 0.7× 10 1.2k

Countries citing papers authored by Maonan Wang

Since Specialization
Citations

This map shows the geographic impact of Maonan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maonan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maonan Wang more than expected).

Fields of papers citing papers by Maonan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maonan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maonan Wang. The network helps show where Maonan Wang may publish in the future.

Co-authorship network of co-authors of Maonan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Maonan Wang. A scholar is included among the top collaborators of Maonan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maonan Wang. Maonan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Lintao, et al.. (2025). MARCH8 ubiquitinates and degrades CEMIP to induce colorectal cancer cell ferroptosis through inactivating PI3K/AKT pathway. Pathology - Research and Practice. 269. 155909–155909. 2 indexed citations
2.
Jiang, Can, Renwei Feng, Yongqian Zhao, et al.. (2025). ITM2A as a potential prognostic marker for triple-negative breast cancer. Journal of Cancer. 16(9). 2903–2916. 1 indexed citations
3.
Zhang, Yuzhu, et al.. (2025). Metabolic reprogramming in cancer and senescence. MedComm. 6(3). e70055–e70055. 5 indexed citations
4.
Li, Nan, et al.. (2025). METTL1 Enhances RRP9 mRNA Stability Through m7G Modification to Drive Colorectal Tumorigenesis. Molecular Carcinogenesis. 64(5). 858–869. 2 indexed citations
5.
Peng, Yahui, Changsong Wang, Hongliu Cai, et al.. (2024). Reduced Viral Shedding Time in High-Risk COVID-19 Patients Infected by Omicron and Treated with Paxlovid: A Real-World Study from China. Infection and Drug Resistance. Volume 17. 1267–1279. 1 indexed citations
6.
Zhu, Houjuan, Maonan Wang, Zibiao Li, et al.. (2024). White light powered antimicrobial nanoagents for triple photothermal, chemodynamic and photodynamic based sterilization. Nanoscale Horizons. 9(7). 1190–1199. 13 indexed citations
7.
Niu, Chenxi, Shutong Wang, Guang Shu, et al.. (2024). Potential prognosis and immunotherapy predictor TFAP2A in pan-cancer. Aging. 16(2). 1021–1048. 3 indexed citations
8.
Shu, Guang, et al.. (2024). Cellular elasticity in cancer: a review of altered biomechanical features. Journal of Materials Chemistry B. 12(22). 5299–5324. 14 indexed citations
9.
Wang, Maonan, Houjuan Zhu, Hua Tian, et al.. (2024). Baiting bacteria with amino acidic and peptidic corona coated defect-engineered antimicrobial nanoclusters for optimized wound healing. Bioactive Materials. 42. 628–643. 6 indexed citations
10.
Wang, Maonan, Jingzhou Zhao, Hui Jiang, & Xuemei Wang. (2022). Tumor-targeted nano-delivery system of therapeutic RNA. Materials Horizons. 9(4). 1111–1140. 35 indexed citations
11.
Wang, Maonan, Hui Jiang, Xiaohui Liu, & Xuemei Wang. (2022). Biophysics involved in the process of tumor immune escape. iScience. 25(4). 104124–104124. 9 indexed citations
12.
Wang, Maonan, Dan Wang, Ting Tang, et al.. (2021). The long noncoding RNA AATBC promotes breast cancer migration and invasion by interacting with YBX1 and activating the YAP1/Hippo signaling pathway. Cancer Letters. 512. 60–72. 27 indexed citations
13.
Wang, Maonan, Jingzhou Zhao, Hongjie Xiong, et al.. (2021). Advance of nano anticancer therapies targeted on tumor-associated macrophages. Coordination Chemistry Reviews. 446. 214126–214126. 9 indexed citations
14.
Wang, Maonan, et al.. (2021). The regulatory networks of the Hippo signaling pathway in cancer development. Journal of Cancer. 12(20). 6216–6230. 30 indexed citations
15.
Feng, Huan, Liang Yin, Maonan Wang, et al.. (2020). Bio responsive self-assembly of Au-miRNAs for targeted cancer theranostics. EBioMedicine. 54. 102740–102740. 24 indexed citations
16.
Wang, Maonan, Lishan Wang, Huan Feng, et al.. (2020). Precise therapeutic effect of self-assembling gold nanocluster–PTEN complexes on an orthotropic model of liver cancer. Journal of Cancer Research and Clinical Oncology. 146(4). 875–882. 10 indexed citations
17.
Wang, Maonan, Zeqian Yu, Huan Feng, et al.. (2019). In situbiosynthesized gold nanoclusters inhibiting cancer developmentviathe PI3K–AKT signaling pathway. Journal of Materials Chemistry B. 7(35). 5336–5344. 20 indexed citations
18.
Wang, Yihan, Huan Feng, Hang Zhang, et al.. (2019). Nanoelectrochemical biosensors for monitoring ROS in cancer cells. The Analyst. 145(4). 1294–1301. 20 indexed citations
19.
Wang, Maonan, Lishen Zhang, Wei Fang, et al.. (2017). Role of tumor microenvironment in tumorigenesis. Journal of Cancer. 8(5). 761–773. 1023 indexed citations breakdown →
20.
Lemaı̂tre, Gérard R. & Maonan Wang. (1995). Active mirrors warped using Zernike polynomials for correcting off-axis aberrations of fixed primary mirrors. I. Theory and elasticity design.. 114. 373. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026